← Eichor
Study identifier: NCT04981119 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Condition: Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer  ·  Sponsor: A2 Biotherapeutics Inc.

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Design: This is a non-interventional, observational study to evaluate participants with solid tumors with a high risk of relapse for incurable disease. No interventional therapy will be administered on this study. Some of the information regarding the participant's tumor analysis may be beneficial to management of their disease. Participants that meet all criteria may be enrolled and leukapheresed (blood cells collected). The participant's cells will be processed and stored for potential manufacture of CAR T-cell therapy upon relapse of their cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials  ·  (310)431-9180  ·  ClinicalTrials@a2bio.com

Always discuss trial participation with your own doctor first.

Locations (16)

Banner HealthGilbert, Arizona, United StatesRecruiting
Mayo Clinic HospitalPhoenix, Arizona, United StatesRecruiting
City of HopeDuarte, California, United StatesCompleted
University of California San DiegoLa Jolla, California, United StatesRecruiting
Stanford UniversityPalo Alto, California, United StatesRecruiting
UCLA Medical CenterSanta Monica, California, United StatesRecruiting
Mayo Clinic JacksonvilleJacksonville, Florida, United StatesRecruiting
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Massachusetts General Hospital/Dana Farber Cancer InstituteBoston, Massachusetts, United StatesCompleted
Mayo Clinic RochesterRochester, Minnesota, United StatesRecruiting
Washington UniversitySt Louis, Missouri, United StatesRecruiting
NYU Langone Medical CenterNew York, New York, United StatesRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04981119